おすすめの製品
由来生物
rabbit
品質水準
100
500
結合体
unconjugated
抗体製品の状態
culture supernatant
抗体製品タイプ
primary antibodies
クローン
SP35, monoclonal
詳細
For In Vitro Diagnostic Use in Select Regions (See Chart)
形状
buffered aqueous solution
化学種の反応性
human
包装
vial of 0.1 mL concentrate (104R-14)
vial of 0.5 mL concentrate (104R-15)
bottle of 1.0 mL predilute (104R-17)
vial of 1.0 mL concentrate (104R-16)
bottle of 7.0 mL predilute (104R-18)
メーカー／製品名
Cell Marque™
テクニック
immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:25-1:100
アイソタイプ
IgG
コントロール
tonsil
輸送温度
wet ice
保管温度
2-8°C
視覚化
cytoplasmic, membranous
遺伝子情報
human ... CD4(920)
詳細
CD4 is a 55-kD glycoprotein expressed on the surface of T-helper/regulatory T-cells,monocytes, macrophages, and some dendritic cells. The majority of peripheral T-celllymphomas are derived from the T-helper/regulatory cell subset so most matureT-cell neoplasms are CD4+. Anti-CD4 is used to identify normal T-cells and to aid in theidentification of neoplasms of T-cell origin.
品質
 IVD |  IVD |  IVD |  RUO |
関連事項
CD4 Positive Control Slides, Product No. 104S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).
物理的形状
Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide
調製ノート
Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.
その他情報
For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com
法的情報
Cell Marque is a trademark of Merck KGaA, Darmstadt, Germany
Not finding the right product?
Try our 製品選択ツール.
試験成績書（COA）
製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
Manual of Diagnostic Antibodies for Immunohistology (2003)
Cynthia Lehe et al.
Cancer research, 68(15), 6350-6359 (2008-08-05)
Compelling evidences indicate a key role for regulatory T cells (T(reg)) on the host response to cancer. The Wilms' tumor antigen (WT1) is overexpressed in several human leukemias and thus considered as promising target for development of leukemia vaccine. However
Adriana Garcia-Herrera et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26(20), 3364-3371 (2008-06-11)
To define the clinical and pathologic characteristics of primary cutaneous small/medium CD4(+) T-cell lymphoma (PCSM-TCL) and identify parameters of prognostic significance. We have investigated 24 patients with primary cutaneous lymphomas composed of small/medium mature T-cells with a betaF1, CD3, CD4(+)
Takashi Akiyama et al.
Pathology international, 58(10), 626-634 (2008-09-20)
The present study reports five CD8+, CD56+ (natural killer (NK)-like) T-cell lymphomas involving the small intestine without evidence of enteropathy, from Japan. Three were intestinal T-cell lymphoma. The site of origin of the other two was not definitive. Four of
Atsushi Tanaka et al.
Cell reports, 43(2), 113810-113810 (2024-02-20)
Metastatic progression of colorectal adenocarcinoma (CRC) remains poorly understood and poses significant challenges for treatment. To overcome these challenges, we performed multiomics analyses of primary CRC and liver metastases. Genomic alterations, such as structural variants or copy number alterations, were
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）